Hyperfine Raises Price to $590K, Reports Record Q4 Growth and India Approval
Hyperfine delivered record Q4 revenue growth driven by expanded device installations and service deployments, launching the first-generation Swoop system in India to broaden international sales. Management set 2026 guidance on growth catalysts across hospitals, office settings and global markets, backed by an MSRP increase from $550,000 to $590,000.
1. Q4 2025 Performance
Hyperfine achieved record revenue growth in Q4 2025 as device installations and service deployments accelerated across its hospital and office customer base, driving a notable uptick in sales activity.
2. Indian Market Entry
Regulatory approval of the first-generation Swoop system in India opens a significant new market, positioning Hyperfine to capture demand in a fast-growing healthcare sector and diversify its geographic footprint.
3. 2026 Guidance and Pricing
Management’s 2026 guidance rests on growth across three verticals—hospitals, office businesses and international markets—while implementing a price increase from $550,000 to $590,000 for U.S. hospital units to enhance revenue per unit.
4. Technology Upgrades and Pipeline
The rollout of Model 2 and Optive AI software has elevated image quality to near high-field MRI standards, underpinning the strongest and most diversified sales pipeline yet, with multi-unit and IDN deals in progress.